aTyr Pharma (LIFE) Misses Q4 EPS by 1c
Get Alerts LIFE Hot Sheet
Join SI Premium – FREE
aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- BMO Capital Reiterates Outperform Rating on CMS Energy (CMS)
- Argus Starts SpaceX (SPCX) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share